AU1461495A - Triazole derivatives - Google Patents

Triazole derivatives

Info

Publication number
AU1461495A
AU1461495A AU14614/95A AU1461495A AU1461495A AU 1461495 A AU1461495 A AU 1461495A AU 14614/95 A AU14614/95 A AU 14614/95A AU 1461495 A AU1461495 A AU 1461495A AU 1461495 A AU1461495 A AU 1461495A
Authority
AU
Australia
Prior art keywords
triazole derivatives
triazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14614/95A
Other languages
English (en)
Inventor
Victor Giulio Matassa
Francine Sternfeld
Leslie Joseph Street
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Publication of AU1461495A publication Critical patent/AU1461495A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU14614/95A 1994-02-02 1995-01-24 Triazole derivatives Abandoned AU1461495A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9402011 1994-02-02
GB9402011A GB9402011D0 (en) 1994-02-02 1994-02-02 Therapeutic agents
PCT/GB1995/000135 WO1995021167A1 (en) 1994-02-02 1995-01-24 Triazole derivatives

Publications (1)

Publication Number Publication Date
AU1461495A true AU1461495A (en) 1995-08-21

Family

ID=10749754

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14614/95A Abandoned AU1461495A (en) 1994-02-02 1995-01-24 Triazole derivatives

Country Status (6)

Country Link
EP (1) EP0741723A1 (ja)
JP (1) JPH09508409A (ja)
AU (1) AU1461495A (ja)
CA (1) CA2182197A1 (ja)
GB (1) GB9402011D0 (ja)
WO (1) WO1995021167A1 (ja)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
ATE148465T1 (de) * 1992-04-10 1997-02-15 Pfizer Acylaminoindolderivate als 5-ht1 agonisten
AU672802B2 (en) * 1992-07-24 1996-10-17 Merck Sharp & Dohme Limited Imidazole, triazole and tetrazole derivatives
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them

Also Published As

Publication number Publication date
WO1995021167A1 (en) 1995-08-10
JPH09508409A (ja) 1997-08-26
CA2182197A1 (en) 1995-08-10
EP0741723A1 (en) 1996-11-13
GB9402011D0 (en) 1994-03-30

Similar Documents

Publication Publication Date Title
AU4000997A (en) Triazolyl derivatives
AU2070795A (en) 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
AU4665596A (en) Pyrazolylbenzoyl derivatives
AU7626596A (en) Oxymethoxy-3-aryl-pyrone derivatives
AU4086296A (en) Indolepiperidine derivatives
AU1195897A (en) Heteroarylcarboxamide derivatives
AU7053296A (en) Purin-6-one derivatives
AU3980995A (en) Antifungal sordaridin derivatives
AU5410498A (en) Pyrazole derivatives
AU4875296A (en) Isoxazolyl-benzoyl derivatives
AU5763596A (en) 2-ureido-benzamide derivatives
AU2485595A (en) 1-Pyridyltetrazolinone derivatives
AU6191796A (en) Sulfonyl- or sulfinylbenzoylguanidine derivatives
AU7084796A (en) Diarylalkenylamine derivatives
AU4547796A (en) Hexahydropyrazinoquinoline derivatives
AU5052296A (en) 4-indolylpiperazinyl derivatives
AU3994095A (en) Thrombocytotic factor
AU4117396A (en) Morpholinoethylamide derivatives
AU689566B2 (en) DC-89 derivatives
AU1382595A (en) Factor viii derivatives
AU6929696A (en) Pyrazol-4-ylbenzoyl derivatives
AU4211296A (en) 4-aminobenzoylguanidine derivatives
AU3619695A (en) Thioquinolone derivative
AU4547396A (en) Thioquinoline derivatives
AU1454895A (en) Diphenyloxazoline derivatives